vs
STANDARD BIOTOOLS INC.（LAB）与ON24 INC.（ONTF）财务数据对比。点击上方公司名可切换其他公司
ON24 INC.的季度营收约是STANDARD BIOTOOLS INC.的1.8倍（$34.6M vs $19.6M），ON24 INC.净利率更高（-18.8% vs -177.4%，领先158.7%），ON24 INC.同比增速更快（-5.6% vs -11.5%），ON24 INC.自由现金流更多（$-2.2M vs $-23.1M），过去两年ON24 INC.的营收复合增速更高（-4.2% vs -12.2%）
Standard BioTools（原Fluidigm公司）是一家美国生命科学工具企业，主营流式细胞术与组织成像分析用质谱流式系统，以及配套的检测试剂盒与试剂，同时供应自动化基因组分析仪器、各类微流控芯片（又称集成流体电路）及配套试剂耗材，全系列产品及应用场景均可提供定制检测方案与相关服务。
ON24 INC.是一家总部位于美国旧金山的企业，为B2B企业的营销与销售团队提供基于云的SaaS服务，开发并提供网络研讨会、虚拟会议、内容中心与着陆页应用，2023年其服务范围已扩展至生成式AI领域。
LAB vs ONTF — 直观对比
营收规模更大
ONTF
是对方的1.8倍
$19.6M
营收增速更快
ONTF
高出5.9%
-11.5%
净利率更高
ONTF
高出158.7%
-177.4%
自由现金流更多
ONTF
多$20.9M
$-23.1M
两年增速更快
ONTF
近两年复合增速
-12.2%
损益表 — Q3 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $19.6M | $34.6M |
| 净利润 | $-34.7M | $-6.5M |
| 毛利率 | 48.5% | 74.9% |
| 营业利润率 | -168.5% | -23.5% |
| 净利率 | -177.4% | -18.8% |
| 营收同比 | -11.5% | -5.6% |
| 净利润同比 | -28.8% | 26.8% |
| 每股收益（稀释后） | $-0.09 | $-0.15 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收LABONTF
| Q4 25 | — | $34.6M | ||
| Q3 25 | $19.6M | $34.6M | ||
| Q2 25 | $21.8M | $35.3M | ||
| Q1 25 | $40.8M | $34.7M | ||
| Q4 24 | — | $36.7M | ||
| Q3 24 | $22.1M | $36.3M | ||
| Q2 24 | $22.5M | $37.3M | ||
| Q1 24 | $45.5M | $37.7M |
净利润LABONTF
| Q4 25 | — | $-6.5M | ||
| Q3 25 | $-34.7M | $-6.4M | ||
| Q2 25 | $-33.5M | $-7.3M | ||
| Q1 25 | $-26.0M | $-8.7M | ||
| Q4 24 | — | $-8.9M | ||
| Q3 24 | $-26.9M | $-11.4M | ||
| Q2 24 | $-45.7M | $-11.2M | ||
| Q1 24 | $-32.2M | $-10.7M |
毛利率LABONTF
| Q4 25 | — | 74.9% | ||
| Q3 25 | 48.5% | 74.7% | ||
| Q2 25 | 48.8% | 75.1% | ||
| Q1 25 | 48.4% | 73.8% | ||
| Q4 24 | — | 74.5% | ||
| Q3 24 | 54.9% | 74.3% | ||
| Q2 24 | 46.1% | 74.5% | ||
| Q1 24 | 53.1% | 74.1% |
营业利润率LABONTF
| Q4 25 | — | -23.5% | ||
| Q3 25 | -168.5% | -23.1% | ||
| Q2 25 | -118.1% | -26.0% | ||
| Q1 25 | -80.8% | -30.1% | ||
| Q4 24 | — | -32.1% | ||
| Q3 24 | -120.9% | -36.7% | ||
| Q2 24 | -134.5% | -35.0% | ||
| Q1 24 | -132.2% | -33.1% |
净利率LABONTF
| Q4 25 | — | -18.8% | ||
| Q3 25 | -177.4% | -18.4% | ||
| Q2 25 | -153.7% | -20.6% | ||
| Q1 25 | -63.8% | -25.1% | ||
| Q4 24 | — | -24.2% | ||
| Q3 24 | -122.0% | -31.4% | ||
| Q2 24 | -203.3% | -29.9% | ||
| Q1 24 | -70.6% | -28.4% |
每股收益（稀释后）LABONTF
| Q4 25 | — | $-0.15 | ||
| Q3 25 | $-0.09 | $-0.15 | ||
| Q2 25 | $-0.09 | $-0.17 | ||
| Q1 25 | $-0.07 | $-0.21 | ||
| Q4 24 | — | $-0.21 | ||
| Q3 24 | $-0.07 | $-0.27 | ||
| Q2 24 | $-0.12 | $-0.27 | ||
| Q1 24 | $-0.27 | $-0.26 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $129.4M | $37.0M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $399.7M | $139.4M |
| 总资产 | $539.6M | $228.4M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资LABONTF
| Q4 25 | — | $37.0M | ||
| Q3 25 | $129.4M | $47.2M | ||
| Q2 25 | $158.6M | $37.7M | ||
| Q1 25 | $150.9M | $26.8M | ||
| Q4 24 | — | $14.9M | ||
| Q3 24 | $210.6M | $11.0M | ||
| Q2 24 | $269.8M | $15.5M | ||
| Q1 24 | $287.1M | $18.3M |
总债务LABONTF
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | $55.2M | — | ||
| Q2 24 | $55.1M | — | ||
| Q1 24 | $55.0M | — |
股东权益LABONTF
| Q4 25 | — | $139.4M | ||
| Q3 25 | $399.7M | $144.3M | ||
| Q2 25 | $424.5M | $150.0M | ||
| Q1 25 | $454.6M | $153.7M | ||
| Q4 24 | — | $159.4M | ||
| Q3 24 | $489.3M | $164.9M | ||
| Q2 24 | $510.3M | $170.8M | ||
| Q1 24 | $577.3M | $174.4M |
总资产LABONTF
| Q4 25 | — | $228.4M | ||
| Q3 25 | $539.6M | $224.8M | ||
| Q2 25 | $557.0M | $235.1M | ||
| Q1 25 | $579.6M | $245.8M | ||
| Q4 24 | — | $251.0M | ||
| Q3 24 | $681.5M | $250.9M | ||
| Q2 24 | $708.7M | $259.0M | ||
| Q1 24 | $777.7M | $269.2M |
负债/权益比LABONTF
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 0.11× | — | ||
| Q2 24 | 0.11× | — | ||
| Q1 24 | 0.10× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-22.2M | $-1.1M |
| 自由现金流经营现金流 - 资本支出 | $-23.1M | $-2.2M |
| 自由现金流率自由现金流/营收 | -118.1% | -6.4% |
| 资本支出强度资本支出/营收 | 4.5% | 3.3% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-111.1M | $4.0M |
8季度趋势，按日历期对齐
经营现金流LABONTF
| Q4 25 | — | $-1.1M | ||
| Q3 25 | $-22.2M | $2.5M | ||
| Q2 25 | $-20.7M | $2.6M | ||
| Q1 25 | $-30.3M | $3.4M | ||
| Q4 24 | — | $985.0K | ||
| Q3 24 | $-27.9M | $295.0K | ||
| Q2 24 | $-39.0M | $1.4M | ||
| Q1 24 | $-62.5M | $2.1M |
自由现金流LABONTF
| Q4 25 | — | $-2.2M | ||
| Q3 25 | $-23.1M | $2.2M | ||
| Q2 25 | $-22.6M | $2.1M | ||
| Q1 25 | $-35.3M | $1.9M | ||
| Q4 24 | — | $424.0K | ||
| Q3 24 | $-30.1M | $143.0K | ||
| Q2 24 | $-41.0M | $898.0K | ||
| Q1 24 | $-63.3M | $1.1M |
自由现金流率LABONTF
| Q4 25 | — | -6.4% | ||
| Q3 25 | -118.1% | 6.2% | ||
| Q2 25 | -103.6% | 5.9% | ||
| Q1 25 | -86.6% | 5.6% | ||
| Q4 24 | — | 1.2% | ||
| Q3 24 | -136.4% | 0.4% | ||
| Q2 24 | -182.2% | 2.4% | ||
| Q1 24 | -138.9% | 2.9% |
资本支出强度LABONTF
| Q4 25 | — | 3.3% | ||
| Q3 25 | 4.5% | 1.1% | ||
| Q2 25 | 8.7% | 1.4% | ||
| Q1 25 | 12.4% | 4.2% | ||
| Q4 24 | — | 1.5% | ||
| Q3 24 | 10.2% | 0.4% | ||
| Q2 24 | 8.6% | 1.3% | ||
| Q1 24 | 1.7% | 2.8% |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
LAB
| Consumables | $8.7M | 45% |
| Services And Other Revenue | $5.8M | 29% |
| Instruments | $5.1M | 26% |
ONTF
暂无分部数据
